• Asacol

  Form: tablets, modified release

  Active substance	Dosage
  mesalazine	1600 mg

  ATC: A07EC02

  Manufacturer: Tilots Pharma AG (manufacturer responsible for batch release)

• Asacol

  Form: tablets, coated, enteric-coated

  Active substance	Dosage
  mesalazine	400 mg

  ATC: A07EC02

  Manufacturer: Haupt Pharma Wülfling GmbH (manufacturing of unpackaged products, primary and secondary packaging)

• Asacol

  Form: tablets, coated, enteric-coated

  Active substance	Dosage
  mesalazine	800 mg

  ATC: A07EC02

  Manufacturer: Haupt Pharma Wülfling GmbH (manufacturing of unpackaged products, primary and secondary packaging)

• Asacol

  Form: suppositories, rectal

  Active substance	Dosage
  mesalazine	500 mg

  ATC: A07EC02

  Manufacturer: Tilots Pharma AG (manufacturer responsible for batch release)

• Mesacol

  Form: tablets, coated, enteric-coated

  Active substance	Dosage
  mesalazine	400 mg

  ATC: A07EC02

  Manufacturer: San Pharmaceutical Industries Ltd

• Mondex

  Form: suppositories

  Active substance	Dosage
  mesalazine	1000 mg

  ATC: A07EC02

  Manufacturer: Kusum HealthCare Pvt Ltd

• Pentasa

  Form: suppositories, rectal

  Active substance	Dosage
  mesalazine	1000 mg

  ATC: A07EC02

  Manufacturer: Ferring International Center SA (manufacturing)

• Pentasa

  Form: tablets, extended-release

  Active substance	Dosage
  mesalazine	500 mg

  ATC: A07EC02

  Manufacturer: Ferring International Center SA (manufacturing)

• Pentasa

  Form: granules, prolonged action

  Active substance	Dosage
  mesalazine	1 g

  ATC: A07EC02

  Manufacturer: Ferring International Center SA (responsible for manufacturing, primary and secondary packaging, quality control)

• Pentasa

  Form: granules, prolonged action

  Active substance	Dosage
  mesalazine	2 g

  ATC: A07EC02

  Manufacturer: Ferring International Center SA (responsible for manufacturing, primary and secondary packaging, quality control)

• Pentasa

  Form: suspension, rectal

  Active substance	Dosage
  mesalazine	1 g/100 ml

  ATC: A07EC02

  Manufacturer: Ferring-Lekhiva a.s.

• Salofalk

  Form: granules, gastroresistant, prolonged-release

  Active substance	Dosage
  mesalazine	500 mg

  ATC: A07EC02

  Manufacturer: Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)

• Salofalk

  Form: granules, gastroresistant, prolonged-release

  Active substance	Dosage
  mesalazine	1000 mg

  ATC: A07EC02

  Manufacturer: Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)

• Salofalk

  Form: granules, gastroresistant prolonged-release

  Active substance	Dosage
  mesalazine	3 g

  ATC: A07EC02

  Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)

• Salofalk

  Form: granules, gastroresistant prolonged-release

  Active substance	Dosage
  mesalazine	1.5 g

  ATC: A07EC02

  Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)

• Salofalk

  Form: suspension, rectal

  Active substance	Dosage
  mesalazine	4 g

  ATC: A07EC02

  Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)

• Salofalk

  Form: suppositories, rectal

  Active substance	Dosage
  mesalazine	250 mg

  ATC: A07EC02

  Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)

• Salofalk

  Form: suppositories, rectal

  Active substance	Dosage
  mesalazine	500 mg

  ATC: A07EC02

  Manufacturer: Dr. Falk Pharma GmbH (responsible for batch release of the final product)

• Salofalk

  Form: suppositories, rectal

  Active substance	Dosage
  mesalazine	1000 mg

  ATC: A07EC02

  Manufacturer: Dr. Falk Pharma GmbH (Responsible for release of final product batches)

• Salofalk

  Form: tablets, coated, enteric-coated

  Active substance	Dosage
  mesalazine	500 mg

  ATC: A07EC02

  Manufacturer: Dr. Falk Pharma GmbH (manufacturer responsible for batch release of the final product)